Evidence map›Paper›PMID 31340837›Full record

ArticleOrphanet journal of rare diseases2019

Assessment of the risk and characterization of non-melanoma skin cancer in Kindler syndrome: study of a series of 91 patients.

Sara Guerrero-Aspizua, Claudio J Conti, Maria Jose Escamez, Daniele Castiglia, Giovanna Zambruno, Leila Youssefian, Hassan Vahidnezhad, Luis Requena, Peter Itin, Gianluca Tadini and 5 more

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Identification of a novelFrontiers in pediatrics · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Epidermolysis bullosa.Nature reviews. Disease primers · 2020
    Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 8 countries.

Sara Guerrero-AspizuaDepartment of Bioengineering, Universidad Carlos III de Madrid, Leganés, Madrid, Spain.
Claudio J ContiDepartment of Bioengineering, Universidad Carlos III de Madrid, Leganés, Madrid, Spain. cconti@ing.uc3m.es.ORCID 0000-0003-4753-0722
Maria Jose EscamezDepartment of Bioengineering, Universidad Carlos III de Madrid, Leganés, Madrid, Spain.
Daniele CastigliaLaboratory of Molecular and Cell Biology, Istituto Dermopatico dell'Immacolata (IDI)-IRCCS, Rome, Italy.
Giovanna ZambrunoGenetic and Rare Diseases Research Area, Bambino Gesù Children's Hospital, IRCCS, Piazza Sant'Onofrio, 4, 00165, Rome, Italy.
Leila YoussefianDepartment of Medical Genetics, Tehran University of Medical Sciences, Tehran, Iran.
Hassan VahidnezhadDepartment of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
Luis RequenaHospital Fundación Jiménez Díaz e Instituto de Investigación FJD, Madrid, Spain.
Peter ItinDepartment of Dermatology, University Hospital Basel, Basel, Switzerland.
Gianluca TadiniPediatric Dermatology, Department of Physiopathology and Transplantation, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico di Milano, University of Milan, Milan, Italy.
Ivelina YordanovaDepartment of Dermatology and Venerology, Medical University Pleven, Pleven, Bulgaria.
Ludovic MartinDepartment of Dermatology, Angers University Hospital, Angers, France.
Jouni UittoDepartment of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
Cristina HasDepartment of Dermatology, University Medical Center Freiburg, Freiburg, Germany.
Marcela Del RioDepartment of Bioengineering, Universidad Carlos III de Madrid, Leganés, Madrid, Spain.
Centre for Biomedical Network Research on Rare Diseases · ESHospital Universitario Fundación Jiménez Díaz · ESBambino Gesù Children's Hospital · ITIstituto Dermopatico dell'Immacolata · ITMedical University Pleven · BGPasteur Institute of Iran · IRTehran University of Medical Sciences · IRThomas Jefferson University · USUniversité d'Angers · FRUniversity Hospital of Basel · CHUniversity Medical Center Freiburg · DEUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKindler Syndrome (KS) is a rare genodermatosis characterized by skin fragility, skin atrophy, premature aging and poikiloderma. It is caused by mutations in the FERMT1 gene, which encodes kindlin-1, a protein involved in integrin signalling and the formation of focal adhesions. Several reports have shown the presence of non-melanoma skin cancers in KS patients but a systematic study evaluating the risk of these tumors at different ages and their potential outcome has not yet been published. We have here addressed this condition in a retrospective study of 91 adult KS patients, characterizing frequency, metastatic potential and body distribution of squamous cell carcinoma (SCC) in these patients. SCC developed in 13 of the 91 patients.

resultsThe youngest case arose in a 29-year-old patient; however, the cumulative risk of SCC increased to 66.7% in patients over 60 years of age. The highly aggressive nature of SCCs in KS was confirmed showing that 53.8% of the patients bearing SCCs develop metastatic disease. Our data also showed there are no specific mutations that correlate directly with the development of SCC; however, the mutational distribution along the gene appears to be different in patients bearing SCC from SCC-free patients. The body distribution of the tumor appearance was also unique and different from other bullous diseases, being concentrated in the hands and around the oral cavity, which are areas of high inflammation in this disease.

conclusionsThis study characterizes SCCs in the largest series of KS patients reported so far, showing the high frequency and aggressiveness of these tumors. It also describes their particular body distribution and their relationship with mutations in the FERMT-1 gene. These data reinforce the need for close monitoring of premalignant or malignant lesions in KS patients.

Indexed as

AdolescentAdultAgedBlisterEpidermolysis BullosaFemaleHumansMaleMembrane ProteinsMiddle AgedNeoplasm ProteinsPeriodontal DiseasesPhotosensitivity DisordersSkin NeoplasmsYoung AdultFERMT1 protein, humanMembrane ProteinsNeoplasm ProteinsBullous diseaseKindler syndromePrevalenceSCCSkin cancer

Identifiers

PMID31340837
PMCPMC6657209
OpenAlexW2963296249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.